A B S T R A C T Immunoprecipitates containing guinea pig Factor VIII antigen were prepared from guinea pig plasma with a cross-reacting rabbit anti-human Factor VIII. Monospecific antisera to guinea pig Factor VIII antigen were produced in rabbits by using these washed immunoprecipitates as immunogens. The resulting antisera to guinea pig Factor VIII antigen detected Factor VIII antigen in guinea pig plasma and inhibited the von Willebrand factor activity in guinea pig plasma. This antibody also detected Factor VIII antigen in a solubilized protein mixture prepared from isolated cultured guinea pig megakaryocytes. Cultured guinea pig megakaryocytes were labeled with radioactive leucine. By radioautography, 96.2% of the radioactivity was present in megakaryocytes. The radioactive Factor VIII antigen present in the solubilized cell protein mixture was isolated by immunoprecipitation and characterized by sodium dodecyl sulfate polyacrylamide gel electrophoresis. The results demonstrate that cultured guinea pig megakaryocytes synthesize Factor VIII antigen which contains the same polypeptide subunit (mol wt 200,000) present in guinea pig plasma Factor VIII antigen.
INTRODUCTION
Immunofluorescence studies performed on a variety of human tissue sections with a monospecific rabbit antihuman Factor VIII have demonstrated that, in vivo, only endothelial cells, platelets, and megakaryocytes contain Factor VIII antigen (VIII:AGN)I (1, 2) . We have Dr. Levine Received for publication 2 December 1976 and in revised form 3 June 1977.
Abbreviations used in this paper: DTT, dithiothreitol; VIII:AGN, Factor VIII antigen; VIII:AHF, Factor VIII procoagulant activity; VIII:VWF, von Willebrand factor; MEM, minimal essential medium; PBS, phosphate-buffered saline; SDS, sodium dodecyl sulfate. previously demonstrated that cultured human endothelial cells synthesize and release a protein(s) whichl has VIII:AGN and von Willebrand factor (VIII:VWF) (3, 4) . We have also demonstrated the presence of VIII:AGN and VIII:VWF in subcellular platelet membrane and granule fractions (5) . The VIII:AGN present in the membrane and granule fractions of human platelets has the same subunit structure as the VIII:AGN in human plasma (5) . Thus, the platelet contains two anatomically separate pools of VIII:AGN and VIII:VWF; one is associated with intracellular granules and the other is associated with the external membrane surface.
The VIII:AGN and VIII:VWF in the surface membrane pool most likely is derived from circulating plasma VIII:AGN and VIII:VWF (6) . The origin of the VIII:AGN and VIII:VWF in the intracellular granule pool is unknown. Proteins such as VIII:AGN probably do not cross cell membranes and therefore it is unlikely that intracellular granule VIII:AGN is derived from plasma. Platelets and megakaryocytes in patients with severe von Willebrand's disease do not contain intracellular VIII:AGN (7) (8) (9) (10) (11) (12) and do not acquire the protein after transfusion (7, 10, 11) . These observations suggest that exogenous plasma VIII:AGN does not gain access to the platelet's interior and suggests that megakaryocytes and (or) platelets synthesize the VIII:AGN and VIII:VWF present in the granule pool. Platelets have no DNA and only a vestigial protein synthetic apparatus; however, megakaryocytes synthesize platelet protein (13) .
Recently, one of us (R. L.) has developed techniques for the isolation and culture of guinea pig megakaryocytes (14, 15) . In this paper, we show that cultured guinea pig megakaryocytes synthesize VIII:AGN which has the same antigenic determinants and subunit molecular weight as guinea pig plasma VIII:AGN.
marrow from four guinea pigs at a time was disaggregated in calciumii-and magnesium-free Hanks' solution containing citrate, adenosine, and theophylline. The marrow cell suspensionl was subjected to density equilibrium centrifugation on a discontinuous albumin gradient with specific gravities of 1.035-1.050. The cells of specific gravity <1.050 were enrichedl in megakaryocytes. This population was subjected to two successive velocity sedimentations at unit gravity. The larger, faster sedimenting cells were mostly megakaryocytes. To quantitate the relative cell volumes, 250 megakaryocytes ancd 250 contaminating cells from each of four separate isolations were sized after the second velocity sedimentation, anid after 20 h in culture, by methods described previously (14) .
The isolated cell population was suspended in Dulbecco's minimiial essential medium (MEM) containing 10% (vol/vol) heat-inactivated, pooled guinea pig serum (Grand Island Biological Co., Grand Island, N. Y.) and 2.3% (wt/vol) bovine albumini (Armour Pharmaceutical Co., Chicago, Ill.). The suspension of megakaryocytes was cultured in glass vials in 5% CO2 at 37°C for 20 h.
Determrinlation of rnegakaryocyte population purity. Megakaryocytes and contaminating cells were countecl in hemocytomiieters (14) . In four different experiments mean cell (liameters were determined with an optical micrometer (14) after isolation and again after overnight culture. At least 250( megakaryocytes and 250 non-megakaryocytes were measured at each point in each experiment. Cultured cell suspensionis were examined by phase contrast and bright-field microscopy (14) to confirm the nature of the contaminating cell types. To exclude the presence of adherent endothelial cells in the cultures, cover slips placed into vials (15) were examinied at the ends of the incubation periods. Immunofluorescenice studies were performed with the rabbit antibody againist guinea pig VIII-AGN (vide infra) followed by fluoresceiniatedl goat anti-rabbit IgG on cultured cell populations spuIn onto glass coverslips as described (3, 14) .
Alegakari ocylte solubilization. In general, studies were performedl on the isolated cultured megakaryocytes obtained from the femurs of 12-16 guinea pigs. At the end ofthe incubations, the cells were harvested by aspirating the contents of the vials. The cells were washed three times with calciumanid magniesium-free Hanks' solution and promptly frozen and( stored at -700C. The cell buttons were thawed and extractedl for 18 h at 4°C with 0.3-0.5 ml of phosphate-buffered saline (PBS, 0.154 M NaCl, 0.01 NM phosphate, pH 7.4) containing 0.1% Lubrol PX (Sigma Chemical Co., St. Louis, Mo.), The rabbit anti-human Factor VIII was used to purify guinea pig VIII:AGN which in turn was used as an immuniogen. The rabbit anti-human Factor VIII appeared to form a line ofpartial ideentity when reacted against human plasma and guiniea pig plasma (Fig. 1 ). An antigen identical to that in guinea pig plasma was detected in the semipurified guinea pig VIII:AGN. The rabbit anti-human Factor VIII was allowed to diffuse against the partially purified guinea pig plasma VIII (14) . Epon sections (Shell Chemical Co., Houston, Tex.) 1 ,um thick were cut on a Porter-Blum MT-2 ultramicrotome (DuPont Instruments, Sorvall Operations, Newtown, Conn.), dried, and dipped into Ilford L4 emulsion melted in a water bath. The slides were dried and kept in the dark for 19 h to 4 days. The autoradiographs were developed in Microdol-X, stained lightly with azure Blue, and examined by bright-field microscopy at a magnification of 2,000. Grains were counted over 96 megakaryocytes and 64 non-megakaryocytes on a single section exposed for 19 h. y-Globulin fractions. These were prepared as previously described (5).
Quantitative immunoelectrophoresis of VIII:AGN. This was carried out as described previously (5) .
SDS polyacrylamide gel electrophoresis. SDS-polyacrylamide gel electrophoresis (5% gels) was performed according to the method of Weber and Osborn, as previously described (5, 17) . Samples for analysis were added to an equal volume of a solution containing 8.5 M urea, 2% SDS, and 14 mM DTT, and boiled for 5 min. Precipitin bands in agar were cut out, heated sufficiently in a water bath to melt the agar, and prepared for gel electrophoresis by solubilization in 100 Al of 8.5 M urea, 2% SDS, 14 mM DTT, and boiled before application on the gel. For some studies, the reducing agent DTT was omitted. Radioactivity labeling patterns were determined by slicing the gels (2-mm slices) and assaying the radioactivity of the individual slices as previously described (17) . The molecular weight of VIII:AGN was determined by SDS acrylamide gel electrophoresis as described (5, 16) .
Anti-VIII:AHF assay. The inhibition of VIII:AHF in guinea pig plasma by rabbit anti-guinea pig VIII:AGN was assayed after equal volumes of antibody and plasma were incubated for 2 h at 37°C. The mixture was assayed for VIII:AHF by a one-stage method with VIII:AHFdeficient human plasma (18) . VIII:AHF was assayed in the megakaryocyte protein solution with this same humandeficient system. Anti-VIII:VWF assay. The inhibition of VIII:VWF in guinea pig plasma by rabbit anti-guinea pig VIII:AGN was assayed with formalin-fixed washed normal hurnan platelets (19) . The assay system included normal guinea pig plasma as a source of VIII:VWF, the rabbit antiserum, and ristocetin (Abbott Laboratories, Chemical Div., North Chicago, Ill.). Aggregation studies were performed with a Payton aggregation module (Payton Associates, Buffalo, N. Y.). In these experiments, the sensitivity of the recording was increased by setting 100% transmission with a dilute platelet suspension (one-half the concentration of the test platelet suspension) rather than with buffer.
RESULTS
Megakaryocyte cultures. The average yield in a single experiment from four guinea pigs was 719,000 megakaryocytes±53,900 (mean+SEM, n = 20). The megakaryocytes comprised 64.5+2.6% (mean+SEM, n = 20) of the freshly isolated total cell populations. The megakaryocytes were much larger than the contaminating cells (mean volumes 15,000 and 420 ,um3, respectively), so that the megakaryocyte cell mass comprised 98.5% of the total. After 20 h in culture the megakaryocytes comprised 44.7+8.5%
(mean±SEM, n = 20) of the cell population by number and 96.1% of the cell mass. No endothelial cells were seen either in the cell suspensions after culture or on cover slips retrieved from the bottoms of the culture vials. Immunofluorescence studies performed on cover slip preparations of cultured cells revealed that Factor VIII:AGN was not detectable in the contaminating erythroid, myeloid, or mononuclear cells but was present in the megakaryocytes.
Guinea pig megakaryocyte and platelet proteins. There were striking similarities in the SDS polyacrylamide gel patterns of the solubilized proteins obtained from isolated cultured guinea pig megakaryocytes and isolated guinea pig platelets (Fig. 2) . A polypeptide of mol wt 200,000 (arrow) was present in both preparations. This polypeptide moved in the same area of the gel as human plasma VIII:AGN and guinea pig plasma VIII:AGN markers.
Specificity of the rabbit anti-guinea pig VIII:AGN. The immunoprecipitate formed by reacting rabbit anti-human Factor VIII and guinea pig VIII:AGN. was used as an immunogen. When the resulting rabbit antibody to guinea pig VIII:AGN was reacted against guinea pig plasma and guinea pig VIII:AGN, a single line of identity was formed (Fig. 3) .
To clarify the specificity of the rabbit anti-guinea pig VIII:AGN, studies were performed to characterize the molecular subunit structure of the antigen precipitated by the antibody. In addition, the antibody's specificity was compared to the known specificity of the rabbit anti-human VIII:AGN. For these studies, immunoprecipitates were formed in agar plates between the respective antibodies and guinea pig plasma. The precipitates were washed, cut out, and analyzed on SDS acrylamide gels. The protein precipitated from guinea pig plasma by the rabbit anti-guinea pig VIII:AGN had the same subunit polypeptide mol wt (200,000) on SDS gels as the protein precipitated from guinea pig plasma by the cross-reacting monospecific rabbit anti-human VIII (Fig. 4) . The protein peaks in the 50,000-and 25,000-mol wt regions represent the H and L chains of the antibodies. The gel pattern for the reduced antibody alone revealed only H and L chains. These studies were performed in the presence of DTT. In the absence of the reducing agent, only intact y-globulin entered the gel. This moved with an apparent mol wt of approximately 100,000 and was identified by comparison with a known IgG marker. These studies demonstrate the VIII:AGN specificity of the rabbit anti-guinea pig VIII:AGN.
The antiserum to guinea pig VIII:AGN did not react with unconcentrated human plasma but did form a faint precipitin with purified human VIII:AGN. The antiserum inhibited the VIII:VWF activity of guinea pig plasma when it was assayed with para-A: formaldehyde-fixed washed human platelets (Fig. 5) .
A control antiserum, rabbit anti-guinea pig fibrinogen, had no inhibitory effect. The rabbit anti-guinea pig VIII:AGN did not inhibit the VII:AHF in normal guinea pig plasma.
VlII:AGN in solubilized megakaryocytes. The rabbit anti-guinea pig VIII:AGN precipitated an antigen in the megakaryocyte protein solution which was similar or identical to an antigen in semipurified guinea pig plasma VIII:AGN (Fig. 6) . By quantitative immunoelectrophoresis, the megakaryo- Time (s) FIGURE 5 Inhibition of ristocetin-induced platelet aggregation by the anti-guinea pig VIII:AGN. 0.4 ml of paraformaldehyde-fixed washed platelets (120,000/,ul in PBS) were incubated with 50 ,ul of normal guinea pig plasma and with 50 ,ul of a 1:5 dilution in PBS of rabbit antiguinea pig VIII:AGN followed by ristocetin (R), 50 ,A, to a final concentration of 0.8 mg/ml. A control experimenit was performed with rabbit anti-guinea pig fibriniogen.
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R. Nachman, R. (Fig. 7B) . To establish that the radioactivity in the TCA-precipitable material was incorporated into protein, the material was digested with the proteolytic enzyme pronase. Digestion with pronase reduced the TCA-precipitable radioactivity in megakaryocyte pro- Radioautography of 1-,um sections of Epon-embedded, [3H]leucine-labeled cells revealed that practically all cell-associated grains were present over the megakaryocytes (Fig. 8) electrophoresis of the radioactive immunoprecipitate of the solubilized megakaryocyte protein (Fig. 9B The interpretation of the results is dependent upon the specificity of the anti-guinea pig VIII:AGN used in these experiments. The immunizing antigen (guinea pig VIII:AGN) was prepared from guinea pig plasma with a cross-reacting monospecific anti-human VIII:AGN which has been previously well characterized (3, 4, 5, 16) . The anti-guinea pig VIII:AGN, when reacted against guinea pig plasma and semipurified guinea pig VIII:AGN, formed a single line of identity (Fig. 3) . This same antibody also detected a single antigen in a preparation of partially purified human Factor VIII:AGN. The protein precipitated from guinea pig plasma by the anti-guinea pig VIII:AGN had the same subunit polypeptide molecular weight on SDS gels as the protein precipitated from guinea pig plasma by the cross-reacting monospecific anti-human VIII:AGN (Fig. 4) . In addition, the anti-guinea pig VIII:AGN inhibited VIII:VWF of normal guinea pig plasma. It was important to prove that the antiserum did not react with cold insoluble globulin, a plasma protein that frequently contaminates Factor VIII preparations (21, 22) . As previously noted, the rabbit anti-human VIII:AGN used to prepare the guinea pig VIII:AGN immunogen did not react with cold insoluble globulin (16) . In addition, the protein precipitated from guinea pig plasma by the anti-guinea pig VIII:AGN had a mol wt of 200,000 on reduced gels and did not enter the gels in the unreduced state. Cold insoluble globulin in unreduced SDS gels moves into the gel with an apparent mol wt of 450,000 (22) . The results demonstrate that the anti-guinea pig VIII:AGN used for these studies was monospecific.
It is of interest that the same antiserum did not inhibit the VIII procoagulant (VIII:AHF) activity of guinea pig plasma. This lack of anti-procoagulant activity is similar to our previous studies with an antiserum prepared against human endothelial cell VIII:AGN-VIII:VWF (4). That antiserum, which 920 R. Nachman, R. Levine, and E. A. Jaffe showed a strong precipitin against human plasma VIII:AGN and was a potent inhibitor of plasma VIII:VWF, was only a very weak inhibitor of plasma VIII:AHF. This dissociation has been previously observed with antisera from rabbits immunized with VIII:AGN derived from hemophilic plasma which contained no detectable VIII:AHF (23, 24) . Variability of VIII:AHF inactivating properties of rabbit antisera has also been observed for animals immunized with different preparations of purified normal human plasma Factor VIII preparations (25) . The radioactive immunoprecipitin study (Fig. 9B ) demonstrated synthesis of VIII:AGN by guinea pig megakaryocytes in culture. This study is similar to our previous studies demonstrating synthesis of VIII: AGN (and presumably VIII:VWF) by cultured human endothelial cells (3, 4, 16) . Human endothelial cell VIII:AGN and guinea pig megakaryocyte VIII:AGN have immunologic, functional, and biochemical similarities. They are immunologically similar or identical to their respective plasma VIII:AGN counterparts ( Fig. 6 and [4] ). Functionally, endothelial cell VIII:AGN and megakaryocyte VIII:AGN appear to be associated with VIII:VWF but lack VIII:AHF. Biochemically, both endothelial cell and megakaryocyte VIII:AGN are composed of polypeptide subunits of 200,000 mol wt. The lack of VIII:AHF in the endothelial cell VIII:AGN appears to be an intrinsic property of the newly synthesized molecule rather than an artifact of the culture conditions (6) . Studies have not yet been performed to determine whether this is also true for the VIII:AGN synthesized by the megakaryocyte in culture.
The biologic importance of megakaryocyte VIII: AGN (and VIII:VWF) synthesis remains to be determined. Studies from several laboratories clearly indicate that exogenous plasma VIII:AGN does not gain access to the platelet intracellular VIII:AGN pool (7, 10, 11) . It thus seems logical to assume that the intracellular platelet VIII:AGN is derived from megakaryocyte synthesis. Patients with aplastic anemia and markedly diminished megakaryocytes have normal plasma VIII:AGN levels.3 Thus, it appears that the endothelial cell is the source of plasma VIII:AGN and platelet surface membrane VIII:AGN while the megakaryocyte is the source of intracellular platelet granule VIII:AGN. It is at present unknown how these two separate VIII:AGN pools interact in normal hemostasis.
